MIRANDA SHELLY: Open Payments
NPI 1679270706 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,760 in 92 payments from 16 companies in 2025. Trend: 2023 $992 · 2024 $2,632 · 2025 $1,760
Food & beverage: $1,760
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $440 |
| Janssen Biotech, Inc. | 14 | $248 |
| QOL Medical, LLC | 7 | $191 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $145 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $133 |
| Ardelyx, Inc. | 6 | $110 |
| PFIZER INC. | 4 | $84 |
| GENZYME CORPORATION | 3 | $82 |
| Phathom Pharmaceuticals, Inc. | 8 | $73 |
| Organon LLC | 3 | $60 |
Products named: TREMFYA, Sucraid, RINVOQ, ENTYVIO, SKYRIZI, IBSRELA, XIFAXAN, DUPIXENT.
Industry payments across VA — which companies pay providers there.
